CIK Cell Transfusion Plus Chemotherapy as Adjuvant Therapy for Stage IB-IIIA Non-Small Cell Lung Cancer (NSCLC)

Stopped Few patients would like to participate ,since CIK cell transfusion was a new treatment and its efficacy was doubted.

Conditions

• Non-small Cell Lung Cancer

Interventions

• DRUG: Autologous CIK Transfusion plus Chemotherapy
• DRUG: chemotherapy alone

Sponsor

Sun Yat-sen University